A Florida woman was sentenced last week in Pittsburgh to probation for conspiring to smuggle misbranded Etizolam, an anti-anxiety medication, into the U.S.
U.S. District Judge Mark Hornak imposed a term of four years on Julie Fees, 29, of Odessa.
Fees had pleaded guilty in 2019 to conspiracy to smuggle drugs and money-laundering conspiracy following an investigation by the Food and Drug Administration and Department of Homeland Security.
In addition to the sentence, she was ordered to forfeit $231,000.
Fees admitted to her role in distributing Etizolam, a thienodiazepine similar to Xanax that carries a risk of dependency and the potential for fatal overdose. The drug is not approved for use in the U.S. by the FDA and is illegal to import.
Fees and her business partner, William Kulakevich, of Alaska, brought Etizolam supplied by Jeetendra Belani, an Indian national, into the U.S. for sale to American customers using multiple post office boxes. Some of those customers were in the Pittsburgh region.
To avoid law enforcement, the pair used fake packaging and lied about the nature of the product on their website.
They paid Belani using wire transfers, virtual currency and cash payments. Fees also admitted to using a shell company, Chicken Little LLC, and related bank accounts to route payments to Belani.
Kulakevich and Belani both pleaded guilty and were sentenced to federal prison.



Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.